Skye Bioscience to Announce Second Quarter 2025 Financial Results and Business Update on August 7, 2025

Investor Relations ir@skyebioscience.com (858) 410-0266 About Skye Bioscience Media Inquiries LifeSci Communications, Michael Fitzhugh mfitzhugh@lifescicomms.com (628) 234-3889 Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next- generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercia ...